In the present study, we investigated the in vitro apoptotic response of leukemic cells to the cellular stress induced by homoharringtonine (HHT), a plant alkaloid with antileukemic activity which is currently being tested for treatment of acute and chronic leukemias. 
Introduction
Sublethal damaging of cellular functions results in cellular stress which is often followed by induction of different endogenous apoptotic programs. Common pathways of programmed cell death implicate critical events like changes of mitochondrial membrane potential (MMP or ⌬⌿), generation of reactive oxygen species (ROS), release of cytochrome c from mitochondria, activation of initiator (eg caspases-8 and -9) and effector caspases (eg caspase-3) as well as regulation of these processes by Bcl-2-related proteins. [1] [2] [3] [4] [5] The relationship and relative significance of these events have been shown to depend critically on the kind of the cellular stress which determines the apoptotic pathway triggered in the target cell. Given the fact that most clinically active anti-cancer agents act by induction of apoptosis, the elucidation of the drug-specific apoptotic cascades is of direct clinical relevance. 6 Homoharringtonine (HHT) is a plant alkaloid with antileukemic activity which is currently being tested for treatment of acute and chronic leukemias. [7] [8] [9] [10] The principal mechanism of action by HHT is the inhibition of protein synthesis in a doseand time-dependent manner by binding to ribosomes and inhibiting polypeptide chain elongation. 11, 12 In fact, its cytotoxicity has been shown to be proportional to the extent of inhibition of protein synthesis. 13, 14 HHT has been shown to induce apoptosis in vitro, however, the main components of HHT-induced apoptotic pathway remain to be identified. 12, 15 In the present study we investigated cell death induced by HHT in human leukemic cells. A comparison of leukemic cell lines with different p53 gene status revealed a considerably higher sensitivity to HHT-induced apoptosis in the cells with a wt p53. As p53 mutations are rare in de novo acute leukemia, [16] [17] [18] apoptotic events in wt p53 leukemia cells were studied in more detail. To this end, we examined central components of apoptotic cascades including Bax expression and its intracellular localization, changes of MMP, ROS levels, cytochrome c release from mitochondria and activation of caspases in the HHT-induced apoptosis.
Materials and methods

Reagents
HHT was obtained from Mingsheng Pharmagen (Zhejiang, China). HHT stock solution was prepared at a concentration of 1 mg/ml in distilled water and kept at 4°C. JC-1, hydroethidine (HE) and Mito Tracker Red CM-H 2 XRos (Mito Tracker) were purchased from Molecular Probes (Leiden, The Netherlands). Dihydrofluorescein-diacetate (DCF), doxorubicin, N-acetyl-l-cysteine (NAC), tiron, vitamin E (␣-tocopherol), butylated hydroxyanisole (BHA), vitamin C (Lascorbic acid) and H 2 O 2 were purchased from Sigma (Deisenhofen, Germany).
Cell lines and cell culture
Human leukemia cell lines used in the study were obtained from the DSM Cell Culture Bank (Braunschweig, Germany). A single-strand conformation polymorphism-polymerase chain reaction (SSCP-PCR) analysis of p53 gene (exons 5-8) revealed mutations in exons 7 and 6 of one p53 allele in P12/Ichikawa and Jurkat cells, respectively, and no p53 mutations in MOLT-3 and MOLT-16 cells (analysis performed by InViTek, Berlin, Germany). All cultures were free of mycoplasma contaminations as assessed by mycoplasma PCR Primer Set kit (Stratagene, Amsterdam, The Netherlands).
Cells were maintained in RPMI 1640 standard medium containing 2 mM L-glutamine and supplemented with 10% heatinactivated fetal calf serum (FCS; Life Technologies, Karlsruhe, Germany). To assess drug-induced effects, 0.2 × 10 6 cells/well were cultured in the presence or absence of HHT in 24-well microtiter plates (Nunc, Wiesbaden, Germany) in standard medium at 37°C in a humidified atmosphere of 5% CO 2 in air.
Assessment of apoptosis
To determine the extent of apoptosis, cells were stained with FITC-conjugated annexin V and PI using the annexin V kit (PharMingen, Hamburg, Germany) according to the manufacturer's instructions. Thereafter, samples were analyzed by flow cytometry (FACScan; Becton Dickinson, Heidelberg, Germany) for the presence of viable (annexin V-and PInegative), early apoptotic (annexin V-positive, PI-negative), and late apoptotic (annexin V-and PI-positive) cells. The extent of apoptosis was quantified as percentage of annexin V-positive cells as described previously. 19 The extent of drugspecific apoptosis was calculated as the difference between the extent of apoptosis after culturing in the presence and absence of the respective drug.
Assessment of p53 and Bax expression, mitochondrial potential and ROS levels by flow cytometry
Bax expression was detected by immunofluorescence as described previously. 19 To assess p53 accumulation, cell preparation (fixation and permeabilization using 1% paraformaldehyde and 100% methanol) and cell staining using antip53 monoclonal mouse antibodies (clone Do1; Oncogene, Boston, MA, USA) were performed according to Bonsing et al. 20 The antigen expression was quantified by flow cytometry in MESF ('molecules of equivalent soluble fluorochrome') units using calibration beads (DAKO FluoroSpheres; DAKO, Glostrup, Denmark) as fluorescence standards. To obtain fluorescence intensities in MESF units, firstly, calibration beads (with known numbers of fluorochrome molecules, ie MESF values, per bead) were measured with FACS and a calibration curve was constructed. Thereafter, at identical FACS settings, experimental samples were measured and MESF values were calculated using the calibration curve.
For the detection of MMP, cells were incubated with JC-1 at final concentration of 10 g/ml (stock solution 2 mg/ml in DMSO) for 10 min at 37°C. HE and DCF were used to measure ROS by staining cells for 30 min at 37°at final concentrations of 10 M (stock solution 10 mM in DMSO) and 20 M (stock solution 20 mM in DMSO), respectively.
Assay for caspase activity and caspase inhibitors
Activation of caspases was detected using colorimetric assays ('Caspase-3', 'Caspase-8' and 'Caspase-9' assay kits; R&D Systems, Wiesbaden-Nordenstadt, Germany) according to the manufacturer's instructions. Briefly, 1 × 10 6 cells were resuspended in 50 l of lysis buffer and 50 l reaction buffer and 5 l chromogenic caspase substrates (peptides DEVD, IETD and LEHD from 'Caspase-3', 'Caspase-8' and 'Caspase-9' assay kits, respectively) conjugated to color reporter molecule p-nitroanaline, pNA, were added. Reaction mixtures were incubated at 37°C for 1 h and the optical density measured at 405 nm.
For caspase inhibition assays, cell-permeable peptide sequences attached to fluoromethylketone (Z-DEVD-fmk, Z-IETD-fmk and Z-LEHD-fmk) from Calbiochem (Nottingham, UK) were used. Caspase inhibitors (stock solutions of 10 mM in DMSO) were added to cells (0.2 × 10 6 /well) at final concentrations of 10-100 M 2 h prior to the addition of drugs.
Expression analysis of bax and GAPDH by RT-PCR
Total RNA was isolated from the cell samples using the Invisorb RNA Kit II (InViTek) according to the manufacturerЈs instructions. cDNA synthesis was performed using the Reverse Transcription System (Promega, Mannheim, Germany) with the supplied oligo(dT) 15 primer. For PCR reactions the following primers were used: GAPDH (fwd: 5Ј-CAT CAG CAA TGC CTC CTG CAC C-3Ј; rev: 5Ј-GTT GAA GTC AGA GGA GAC CAC C-3Ј) and bax (fwd: 5Ј-ACC AAG AAG CTG AGC GAG TGT C-3Ј; rev: 5Ј-TGT CCA GCC CAT GAT GGT TC-3Ј), giving products of 424 bp and 255 bp, respectively. Taq-Polymerase and PCR reagents were supplied by InViTek. RT and PCR reactions were performed using the Omnigene cycler (Hybaid, Heidelberg, Germany). Samples were resolved on a 1.5% agarose gel, visualized with ethidium bromide using the EagleeyeII optical system (Stratagene) and quantified with the Adobe Photoshop software program. All tests were performed in triplets.
Intracellular localization studies of Bax, cytochrome c and mitochondria by confocal microscopy
Cells were first stained for mitochondria by incubation with Mito Tracker (0.3 mM) for 30 min at 37°C. Thereafter, cells were washed and stained with annexin-FITC as described above. Finally, cells were fixed and permeabilized by Fix and Perm (An der Grub, Kaumberg, Austria) and incubated with mouse monoclonal antibodies either against Bax (clone YTH-2D2; Trevigen, Gaithersburg, MD, USA) or cytochrome c (clone 6H2.B4; PharMingen) and with Cy5-conjugated secondary antibodies (goat anti-mouse; Caltag). Three-color fluorescence was analyzed using MultiProbe 2010 confocal laser microscope (Molecular Dynamics, Sunnyvale, CA, USA) equipped with a krypton-argon laser and Indy workstation (Silicon Graphics, Mountain View, CA, USA). In addition to leukemic T cell lines we also tested the p53-null myeloid leukemic cell lines HL60 and K562. These cell lines revealed dose-dependent HHT sensitivity which was similar to that of Jurkat and P12 cells with mut/wt p53 (data not shown). 
Results
Dose and time dependence of HHT-induced apoptosis in cell lines with different p53 status
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Loss of MMP and cytochrome c release in HHTinduced apoptosis
In order to investigate an involvement of MMP changes in the HHT-induced apoptosis in MOLT-3 cells, we used potentiometric dye JC-1 (Figure 2 ). JC-1 is a fluorescent dye which reveals different emission spectra in aggregated and free forms, the latter one being shifted towards green fluorescence (region R1, Figure 2) . Percentages of apoptotic, annexin Vpositive cells (40%) and JC-1-stained, 'green' cells (44%) were nearly the same, thus indicating that HHT-induced apoptosis involves a decrease or loss of MMP.
To detect whether a cytochrome c release is involved in HHT-induced apoptosis, colocalization between mitochondria and cytochrome c was examined by confocal laser microscopy ( Figure 3) . Cytochrome c was found to be highly colocalized with mitochondria in HHT-untreated cells ( Figure  3a) . By contrast, cells exposed to HHT exhibited diffuse cytoplasmic distribution of cytochrome c (Figure 3b-d) . This out of mitochondria localization of cytochrome c was observed already after the incubation period of 6 h at which no morphological signs of apoptosis or annexin V-staining characteristic of apoptosis were found (Figure 3b) . 
Bax expression and localization
Involvement of the pro-apoptotic factor Bax in HHT-induced apoptosis was studied at three different levels: mRNA expression, protein expression and intracellular localization. Using RT-PCR, we found a modest (statistically significant at 50 ng/ml HHT, P Ͻ 0.05) upregulation of Bax-specific mRNA (Figure 4 ). However, at protein level, decreased levels of Bax expression were observed (Figure 4 ). Intracellular distribution of Bax and its colocalization with mitochondria, studied using three-color scanning microscopy, showed significant changes following HHT treatment ( Figure  5 ). In fact, while Bax had been initially distributed throughout the whole cell with a low degree of colocalization with mitochondria (Figure 5a ), a high degree of Bax colocalization with 
Involvement of caspases in HHT-induced apoptosis
We next examined whether caspase activation is involved in HHT-induced apoptosis. Colorimetric assays revealed cleavage activity of DEVD-, IETD-and LEHD-tetrapeptides conjugated with color reporter molecule pNA in cell lysates of HHT-treated MOLT-3 cells (Figure 6 ). Co-incubation of MOLT-3 cells with corresponding inhibitors (Z-DEVD-, -IETDand -LEHD-tetrapeptides conjugated with fmk) abolished (DEVD) or substantially reduced (IETD and LEHD) HHTinduced cleavage activity ( Figure 6 ).
Using the same caspase inhibitors, we also investigated their effects on HHT-induced apoptosis as characterized by annexin V binding. Caspase inhibitors revealed dose-dependent inhibition of apoptosis in the concentration range of 10-50 M (data not shown), with the extent of inhibition approximately the same at concentrations of 50 and 100 M ( Figure  7) . In contrast to the binding of annexin V, HHT-induced loss of MMP was not affected by the caspase inhibitors (Figure 7) .
Induction of ROS and effect of antioxidants in HHTinduced apoptosis
ROS have been reported either to be generated during the late stages of apoptosis or to play an active role as an apoptotic second messenger. To investigate an involvement of ROS in HHT-induced apoptosis, we studied ROS levels in MOLT-3 cells using HE and DCF dyes. While no changes between con-
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Figure 7
Inhibition of caspases prevents apoptosis but does not affect MMP in HHT-treated MOLT-3 cells. Cells were incubated either with HHT (25 ng/ml) alone (control) or in the presence of caspase inhibitors (100 M). trol and HHT-treated cells were found in respect to DCF-staining (not shown), a low but distinct increase of staining with HE was observed (Figure 8a) . We further examined, whether different antioxidants could affect the increased HE staining levels. Of the reagents tested (vitamins E and C, BHA, tiron, NAC) only NAC was able to reduce ROS levels (not shown and Figure 8b ). Therefore, we applied NAC to investigate whether inhibition of ROS generation could affect the loss of MMP and apoptosis. No changes of annexin V staining (ie apoptosis levels) and JC-1 staining (ie MMP levels) were observed in the presence of NAC in HHT-treated cells (Figure 8c and d) , although NAC was able to prevent apoptosis observed in control experiments with H 2 O 2 -treated MOLT-3 cells (Figure 9 ).
Discussion
In the present study, we investigated the mechanism of apoptotic response in leukemic cells to the cellular stress induced by anti-leukemic agent HHT. Although HHT has been suggested to be effective in treating acute myeloid leukemia but not acute lymphoblastic leukemia, 12 we did not observe cell type-dependent sensitivity to HHT. In fact, the myeloid leukemia cell lines K562 and HL-60 did not reveal higher sensitivity to HHT than the leukemic cell lines of lymphoid origin.
A comparison of leukemic cell lines with different p53 gene status revealed a considerably higher sensitivity to HHTinduced apoptosis in the cells with a wt p53. Given a rather low frequency of p53 mutations in de novo acute leukemia, [16] [17] [18] we were interested to investigate HHT-induced cascade of apoptotic events in wt p53 leukemia cells in detail. We observed p53 accumulation in HHT-treated MOLT-3 cells prior to apoptotic cell death (Figure 1 ). Although p53 accumulation has been initially described to be induced in response to DNA damage, 21 ,22 the list of p53-inducing stimuli now includes diverse stress conditions such as hypoxia, 23 heat shock, 24 dominant oncogene expression 25 or nucleotide depletion. 26 Apoptosis and p53 stabilization induced by transcription inhibition have also been described. 27, 28 The mechanisms linking cellular stress induced by RNA (eg ␣-amanitin 27, 28 ) or protein (eg HHT) synthesis inhibitors to the p53 activation are not clear. Interestingly, An et al 28 suggested that the accumulation of p53 could result from reduced p53 degradation rate due to the downregulation of Mdm-2 protein, the negative p53 regulator responsible for the p53 targeting to proteasomal degradation.
A broad spectrum of transcriptional targets of p53 has recently been identified, including pro-apoptotic Bax, 29 death receptors CD95 and DR5, 30, 31 as well as novel effectors of apoptosis PERP 32 and Noxa. 33 In addition, p53 might be responsible for the generation of ROS. 34 Furthermore, several direct lines of evidence imply that the pro-apoptotic activity of p53 might be independent of its function as a transcription factor. 35, 36 The pathways whereby p53 leads to execution of apoptotic program seem to be multiple and may strongly depend on the cell type and the nature of apoptotic stimuli.
The apoptotic pathways induced by HHT have not yet been described, and, here, we addressed involvement of key events of apoptotic programs reported in a number of experimental systems. In particular, the role of ROS and Bax as well as mitochondrial cytochrome c release as downstream mediators in the anti-cancer drug-induced apoptosis and in the models of apoptosis induced by transient p53-overexpression have been recently controversially discussed. 3, 34, [37] [38] [39] In the model of ROS-driven apoptosis, the generation of ROS has been suggested as a primary regulatory component followed by the activation of caspases and caspase-dependent loss of MMP. 34, 38 Consequently, this form of cell death could be prevented by antioxidants. However, in our study, ROS levels only slightly increased in HHT-treated cells. Moreover, the antioxidant NAC, which was found to decrease ROS-levels in MOLT-3 cells and to inhibit H 2 O 2 apoptosis, did not prevent apoptosis and MMP changes. Therefore, our data indicate that ROS generation might not be involved in the upstream events of HHT-induced apoptosis.
In the ROS-dependent form of apoptosis, an upregulation of Bax has been observed, however, neither translocation to mitochondria nor cytochrome c release has been found. 38 In the model of Bax-driven apoptosis, an upregulation of Bax as a direct target of the p53-transcription regulating activity has been reported. 1, 29, 40 In addition, a translocation of Bax from cytosol to mitochondrial membrane has been observed in some experimental systems. 41, 42 As a result, Bax has been shown to induce changes of mitochondrial membrane permeability, cytochrome c release from mitochondria and consequent activation of initiator caspase-9 and effector caspase-3. 39, [43] [44] [45] In this form of apoptosis, ROS generation has been observed which could, however, be prevented by inhibition of caspases and has therefore been considered to be the late event of apoptosis. 46 In the current study, expression levels of Bax protein did not increase, consistent with the principal mechanism of HHT action as protein synthesis inhibitor. 11, 12 However, we observed Bax translocation towards mitochondria as well as mitochondrial cytochrome c release at early stages of apoptosis. These localization changes of Bax and cytochrome c in relation to mitochondria as well as MMP loss indicate implication of mitochondria in the HHT-induced apoptosis. The observed activation of caspases is consistent with this assumption. Recently, caspases involved in apoptosis have been subgrouped into two groups according to cleavage specificities of tetrapeptide substrates. 47 The DExD peptide recognition motif has been found to be optimal for caspases-2, -3, -7 (group II), and the (I/L/V)ExD sequence for caspases-6, -8, -9 (group III). 47, 48 The observed DEVD, IETD and LEHD cleavage activities in cell lysates from HHT-treated cells as well as inhibition of apoptosis by these tetrapeptides indicate an involvement of caspases from both groups in HHT-induced cell death.
Taken together, our data represent detailed analysis of HHT-induced apoptotic cascade in leukemic cells with wt p53. The observed apoptotic pathway characterized by translocation of Bax, mitochondrial cytochrome c release and caspase activation might be the principal mechanism underlying the antileukemic activity of HHT.
